Published: Jan 30, 2021, 05:45 IST | Updated: Jan 30, 2021, 05:45 IST
Johnson & Johnson Coronavirus vaccine has shown an overall 66% efficacy in preventing moderate to severe COVID-19. Although the trial results indicate that it is less effective against the virus variant first discovered in South Africa.